CONy16: Should RRMS Disease-Modifying Drugs Be Used to Treat Secondary Progressive MS?
A major dilemma facing clinicians is whether to continue treatment with disease-modifying drugs, effective in relapsing-remitting multiple sclerosis (RRMS), as the disease progresses to secondary progressive MS (SPMS). In SPMS, these treatments seem to lose their benefits and — as they are often associated with severe side effects and high costs — clinicians…